Radioisotopes in the diagnosis of ocular melanoma were formerly extensively used in the 32P test. Both, the necessity of a surgical procedure to place a probe onto the sclera for 13-count measurement and some false positive results, due to the non-specific tracer accumulation, raised doubts ofits clinical value.2 Another attempt was the administration of "Cr bleomycin, a non-specific oncophilic radiopharmaceutical. Sensitivity and specificity were reported to be satisfactory.3 Patients in an advanced stage of the disease however were also included and no data on the lesion size were provided.
Radioisotopes in the diagnosis of ocular melanoma were formerly extensively used in the 32P test. Both, the necessity of a surgical procedure to place a probe onto the sclera for 13-count measurement and some false positive results, due to the non-specific tracer accumulation, raised doubts ofits clinical value.2 Another attempt was the administration of "Cr bleomycin, a non-specific oncophilic radiopharmaceutical. Sensitivity and specificity were reported to be satisfactory.3 Patients in an advanced stage of the disease however were also included and no data on the lesion size were provided. (Fig 1) .
Detectability has shown a positive correlation with the thickness of the lesions measured by ultrasound echography: .4 mm 57%, .6 mm 73%, c8 mm 83%, and >8 mm 100% of choroidal melanomas were positive in IS. Mela- (Fig 2) . Fifteen of 16 non-melanoma lesions were truly negative (specificity 94%). A slight accumulation of radioactivity in both eyes was seen in one patient with bilateral naevi in the SPECT slices only. This accumulation was not considered to be a positive result. All other naevi and the nonmelanoma metastases were negative. One false positive result was obtained in an old subretinal post-traumatic haemorrhage simulating a tumour mass (thickness 7-4 mm). IS could demonstrate the HMW-MAA in all sections examined (Fig 3 and Table 1 ).
Discussion
Our data show that lesions of a size even below an order of magnitude of resolution can be visualised. Thus the rate of antibody uptake seems to be the decisive parameter for tumour detection by IS. According to a recent study'2 the expression of HMW-MAA was reported in all melanoma sections examined by immunohistochemistry though choroidal melanoma exhibited antigenic heterogeneity.'9 Considering the small number of melanomas tested in all immunohistological studies, this suggested heterogeneity can be responsible for a sensitivity of IS below 100%.
Conventional planar scintigraphy proved not to be sufficient for immunoscintigraphic imaging of choroidal melanomas. Taking into account the small size of melanomas, SPECT, the most advanced imaging technique in nuclear medicine, was used additionally and compared with conventional scintigraphy. SPECT images are created by a technique similar to x ray computer tomography, which offers the selection ofdefined sections in transversal, frontal, and sagittal projection. Compared with planar scintigraphy SPECT provides equal at-best resolution, improved contrast without superimposed background activity, and better three-dimensional orientation. However, even with the SPECT imaging technique intraocular melanomas smaller than 2 7 mm in size were invisible. Although brain metastases can be demonstrated by IS, non-specific activity accumulation makes the exclusion of liver metastases impossible. Occurrence of non-specific tracer uptake in liver, nasopharynx, and bone marrow is due to the well-known transchelation of DTPA-bound 'Tc to transferrin and its accumulation in the reticuloendothelial system. Activity accumulation in the kidneys representing the physiological route for the excretion of antibody fragments (F(ab')2). Surprisingly, there was no significant difference in sensitivity between melanomas of nasal or temporal location as the Counterstaining is responsiblefor black colour reactions ofnuclei.
non-specific nasopharyngeal uptake did not interfere with the detection of nasally located lesions.
All tumour markers used at present are not specific for a certain tumour, they are just expressed in a higher quantity by malignancies compared with normal tissue. The HMW-MAA is also present in skin naevi. Up to now there are no immunohistological data regarding the presence of this antigen in choroidal naevi. Normal eyes do not react with antibodies against the HMW-MAA.'2 In our study only one out of eight naevi revealed a slight antibody uptake while all intraocular metastases were negative. These results are in agreement with Bomanji, 20 who reported antibody accumulation in a large flat choroidal naevus. The presence of this antigen may indicate malignant transformation of the naevus. In the 2 year follow-up of this patient no clinical signs for tumour progression were encountered. Intensive activity accumulation was visualised in a second non-melanoma lesion, a subretinal haemorrhage following trauma. Haemorrhages can possess a higher blood pool which may be a possible explanation for this false positive result.
In conclusion, IS with MoAbs against the HMW-MAA proved to be a valuable diagnostic method which offers substantial sensitivity and specificity for the differentiation of intraocular space occupying lesions, particularly choroidal melanoma, naevus, and metastasis. It may add valuable information when the diagnosis cannot be confirmed by other diagnostic methods. Prospects for the future are the development of MoAbs against tumour antigens specific for choroidal melanoma2' as well as the injection of antibody cocktails against different epitopes,2" or the application of melanoma-specific haptens23 to improve immunoimaging of choroidal melanoma.
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